News Snapshot:
To activate the text-to-speech service, please first agree to the privacy policy below. CNA photo May 18, 2021 Taipei, May 18 (CNA) A Taiwan-developed Chinese medicine formula used alongside Western medicine to treat COVID-19 patients could be approved for use in Taiwan as early as this week, according to a senior official at the Ministry of Health and Welfare (MOHW). The medicine, known as NRICM 101, was developed last year by the MOHW's National Research Institute of Chinese Medicine and a team of clinical practitioners using a mixture of 10 traditional ingredients. Since then, Taiwan's Tri-Service General Hospital, Chang Gung...
